NORDIC PHARMA LIMITEDActive
Key figures
NORDIC PHARMA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Profit for the year | — | -409,584 | 16,266,965 |
| Cash at bank and in hand | 142 | 4,843,858 | 3,482,014 |
| Total assets | 4,612,601 | 14,347,605 | 15,939,761 |
| Total liabilities | 4,444,326 | — | 4,147,083 |
| Net assets / total equity | 32,007 | 2,225,713 | 11,792,678 |
| Average number of employees | 29 | 28 | 0 |
| Average pay (per year) | — | 86,948 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company and group continued to be that of the sale and distribution of pharmaceutical products and medical devices.
As described in the company's latest filed accounts.
Summary: NORDIC PHARMA LIMITED
Company
NORDIC PHARMA LIMITED is a private limited company registered with Companies House under company number 01489084. It was incorporated on 2 Apr 1980. Its status is active. The registered office is in Theale (RG7). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files group accounts. Profit for the year was £16,266,965. Net assets were £11,792,678, up 429.8% on the previous year. Cash at bank and in hand was £3,482,014. Total assets were £15,939,761 and total liabilities £4,147,083. The company had an average of 0 employees. Figures are available for 3 financial years (2023–2025).
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 18 May 2027.